FI964749A0 - Asyloituja enolijohdannaisia elastaasi-inhibiittoreiden lääkkeen esiasteina - Google Patents

Asyloituja enolijohdannaisia elastaasi-inhibiittoreiden lääkkeen esiasteina

Info

Publication number
FI964749A0
FI964749A0 FI964749A FI964749A FI964749A0 FI 964749 A0 FI964749 A0 FI 964749A0 FI 964749 A FI964749 A FI 964749A FI 964749 A FI964749 A FI 964749A FI 964749 A0 FI964749 A0 FI 964749A0
Authority
FI
Finland
Prior art keywords
elastase inhibitors
drug precursors
enol derivatives
acylated enol
acylated
Prior art date
Application number
FI964749A
Other languages
English (en)
Swedish (sv)
Other versions
FI964749A (fi
Inventor
Norton Paul Peet
Joseph Paul Burkhart
Shujaath Mehdi
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of FI964749A publication Critical patent/FI964749A/fi
Publication of FI964749A0 publication Critical patent/FI964749A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI964749A 1994-06-02 1996-11-28 Asyloituja enolijohdannaisia elastaasi-inhibiittoreiden lääkkeen esiasteina FI964749A0 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25279894A 1994-06-02 1994-06-02
US42085995A 1995-04-19 1995-04-19
PCT/US1995/005879 WO1995033478A1 (en) 1994-06-02 1995-05-08 Acylated enol derivatives as prodrugs of elastase inhibitors

Publications (2)

Publication Number Publication Date
FI964749A FI964749A (fi) 1996-11-28
FI964749A0 true FI964749A0 (fi) 1996-11-28

Family

ID=26942673

Family Applications (1)

Application Number Title Priority Date Filing Date
FI964749A FI964749A0 (fi) 1994-06-02 1996-11-28 Asyloituja enolijohdannaisia elastaasi-inhibiittoreiden lääkkeen esiasteina

Country Status (20)

Country Link
US (2) US5698523A (fi)
EP (1) EP0762887B1 (fi)
JP (1) JP4221059B2 (fi)
KR (1) KR100367389B1 (fi)
CN (1) CN1149833A (fi)
AT (1) ATE206055T1 (fi)
AU (1) AU696292B2 (fi)
CA (1) CA2191844C (fi)
DE (1) DE69522940T2 (fi)
DK (1) DK0762887T3 (fi)
ES (1) ES2161293T3 (fi)
FI (1) FI964749A0 (fi)
HU (1) HU221310B1 (fi)
IL (1) IL113869A (fi)
MX (1) MX9606034A (fi)
NO (1) NO317185B1 (fi)
NZ (1) NZ287604A (fi)
PT (1) PT762887E (fi)
TW (1) TW406087B (fi)
WO (1) WO1995033478A1 (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6008196A (en) * 1994-06-02 1999-12-28 Hoechst Marion Roussel, Inc. Perfluoroalkyl ketone inhibitors of elastase and processes for making the same
JP4221059B2 (ja) * 1994-06-02 2009-02-12 アベンティス・インコーポレイテッド エラスターゼインヒビターのプロドラッグとしてのアシル化エノール誘導体
US5948886A (en) * 1996-11-20 1999-09-07 Hoechst Marion Roussel, Inc. Acylated enol derivatives of α-ketoesters and α-ketoamides
US6172044B1 (en) 1995-12-01 2001-01-09 Aventis Pharmaceuticals Inc. Acylated enol derivative of α-ketoesters and α-ketoamides
WO2008060621A2 (en) * 2006-11-17 2008-05-22 Abbott Laboratories Aminopyrrolidines as chemokine receptor antagonists

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4308384A (en) * 1978-09-18 1981-12-29 Glaxo Group Limited Production of triazinones
US4277395A (en) * 1980-06-16 1981-07-07 Richardson-Merrell Inc. Novel enzyme inhibitors
US4518528A (en) * 1983-05-19 1985-05-21 Rasnick David W α Amino fluoro ketones
DE3324534A1 (de) * 1983-07-07 1985-01-17 Ciba-Geigy Ag, Basel Modifizierte protease-inhibitoren, verfahren zu ihrer herstellung und daraus bereitete pharmazeutische mittel
CA1267499A (en) * 1983-07-12 1990-04-03 Cedric H. Hassall Peptide amides and aldehydes
US4629724A (en) * 1984-12-03 1986-12-16 E. R. Squibb & Sons, Inc. Amino acid ester and amide renin inhibitors
US4643991A (en) * 1984-12-18 1987-02-17 The University Of Kentucky Research Foundation Peptide elastase inhibitors and methods
US5055450A (en) * 1985-01-22 1991-10-08 Ici Americas Inc. Peptide derivatives
GB8600263D0 (en) * 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives
US5496927A (en) * 1985-02-04 1996-03-05 Merrell Pharmaceuticals Inc. Peptidase inhibitors
ZA86746B (en) * 1985-02-04 1986-09-24 Merrell Dow Pharma Novel peptidase inhibitors
DE3683541D1 (de) * 1985-06-07 1992-03-05 Ici America Inc Selektionierte difluorverbindungen.
GB8613703D0 (en) * 1986-06-05 1986-07-09 Ici America Inc Difluoro peptide compounds
US4935405A (en) * 1986-10-31 1990-06-19 Pfizer Inc. Nor-statine and nor-cyclostatine polypeptides
US4855303A (en) * 1987-07-01 1989-08-08 Pfizer Inc. Fluorine containing renin inhibitors
EP0318318A1 (en) * 1987-11-27 1989-05-31 Sensititre Limited Urine assay process and kit
WO1992015605A2 (en) * 1991-03-01 1992-09-17 Protein Engineering Corporation Inhibitors of human neutrophil elastase and human cathepsin g
US5162307A (en) * 1988-09-09 1992-11-10 Board Of Trustees Of The University Of Kentucky Polymer bound elastase inhibitors
EP0371179A1 (en) * 1988-10-28 1990-06-06 Merrell Dow Pharmaceuticals Inc. Novel analogs of peptidase substrates
EP0369391A3 (en) * 1988-11-15 1991-09-25 Boehringer Ingelheim Pharmaceuticals Inc. N-substituted amides
CA2021660A1 (en) * 1989-07-26 1991-01-27 Philippe Bey Peptidase inhibitors
US5221665A (en) * 1989-10-27 1993-06-22 Boehringer Ingelheim Pharmaceuticals, Inc. N-substituted amides
IL97428A0 (en) * 1990-03-05 1992-06-21 Cephalon Inc Chymotrypsin-like proteases and their inhibitors
EP0480044A4 (en) * 1990-03-30 1993-06-09 Japan Tobacco Inc. Novel 4h-3,1-benzoxazin-4-one derivative
JPH06504547A (ja) * 1990-12-28 1994-05-26 ジョージア・テック・リサーチ・コーポレーション ペプチドケトアミド、ケト酸およびケトエステル
US5296591A (en) * 1990-12-31 1994-03-22 Fujisawa Pharmaceutical Co., Ltd. Trifluoromethylketone derivatives, processes for preparation thereof and use thereof
HU217612B (hu) * 1991-05-23 2000-03-28 Merrel Dow Pharmaceuticals Inc. Eljárás elasztáz és katepszin G inhibitor hatású peptidek előállítására
AU655831B2 (en) * 1991-08-22 1995-01-12 Merrell Pharmaceuticals Inc. Novel orally-active elastase inhibitors
US5478811A (en) * 1991-08-22 1995-12-26 Merrell Dow Pharmaceuticals Inc. Orally-active elastase inhibitors
PT721449E (pt) * 1993-10-01 2002-06-28 Merrell Pharma Inc Inibidores da producao da proteina beta-amiloide
US6008196A (en) * 1994-06-02 1999-12-28 Hoechst Marion Roussel, Inc. Perfluoroalkyl ketone inhibitors of elastase and processes for making the same
AU689589B2 (en) * 1994-06-02 1998-04-02 Hoechst Marion Roussel, Inc. Novel elastase inhibitors
JP4221059B2 (ja) * 1994-06-02 2009-02-12 アベンティス・インコーポレイテッド エラスターゼインヒビターのプロドラッグとしてのアシル化エノール誘導体

Also Published As

Publication number Publication date
ES2161293T3 (es) 2001-12-01
US5972897A (en) 1999-10-26
EP0762887B1 (en) 2001-09-26
DE69522940T2 (de) 2002-04-04
KR100367389B1 (ko) 2003-07-18
WO1995033478A1 (en) 1995-12-14
CA2191844C (en) 2001-07-24
EP0762887A1 (en) 1997-03-19
HU9603309D0 (en) 1997-01-28
IL113869A (en) 2000-01-31
FI964749A (fi) 1996-11-28
NO965099L (no) 1997-01-31
HUT76131A (en) 1997-06-30
PT762887E (pt) 2002-01-30
AU2636695A (en) 1996-01-04
JP4221059B2 (ja) 2009-02-12
CA2191844A1 (en) 1995-12-14
HU221310B1 (en) 2002-09-28
NO965099D0 (no) 1996-11-29
ATE206055T1 (de) 2001-10-15
JPH10501221A (ja) 1998-02-03
NZ287604A (en) 1998-12-23
IL113869A0 (en) 1995-08-31
EP0762887A4 (en) 1999-03-31
DK0762887T3 (da) 2002-01-14
US5698523A (en) 1997-12-16
AU696292B2 (en) 1998-09-03
TW406087B (en) 2000-09-21
NO317185B1 (no) 2004-09-13
CN1149833A (zh) 1997-05-14
DE69522940D1 (de) 2001-10-31
MX9606034A (es) 1998-05-31

Similar Documents

Publication Publication Date Title
BR9502707A (pt) Composto composição farmacêutica e método para o tratamento de uma afecção
IS2241B (is) Píperasín afleiður og notkun þeirra sem bólgueyðandi miðlar
NO995544L (no) Forbindelser og metoder for inhibering av ekspresjonen av VCAM-1
BR0008922A (pt) Compostos úteis como agentes antiinflamatórios
NO20012995L (no) Forbindelser nyttige for behandling av inflammatoriske sykdommer
NO20031442D0 (no) Morfolin-acetamidderivater for behandling av inflammatoriske sykdommer
AP2000001761A0 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.
GR3034575T3 (en) Steroid nitrite ester derivatives useful as anti-inflammatory drugs
FI964749A0 (fi) Asyloituja enolijohdannaisia elastaasi-inhibiittoreiden lääkkeen esiasteina
PT804465E (pt) Novos inibidores da elastase
MX9804265A (es) Derivados de enol acilado de a-cetoesteres y a-cetoamidas.
AP2000001760A0 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.
PT1077694E (pt) Produtos terapeuticos de arilnitrona para o tratamento da doenca inflamatoria dointestino
WO1999025327A3 (en) Small molecule intervention in hiv-1 replication

Legal Events

Date Code Title Description
MA Patent expired